Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 362)
Posted On: 12/08/2020 2:50:40 PM
Post# of 36564
Posted By: KRR
COVID-19 mRNA Vaccine is not recommended during pregnancy.

There are no or limited amount of data from the use of COVID-19 mRNA Vaccine BNT162b2.
Animal reproductive toxicity studies have not been completed.
For women of childbearing age, pregnancy should be excluded before vaccination. In addition, women
of childbearing age should be advised to avoid pregnancy for at least 2 months after their second dose.
It is unknown whether COVID-19 mRNA Vaccine BNT162b2 is excreted in human milk. A risk to
the newborns/infants cannot be excluded. COVID-19 mRNA Vaccine BNT162b2 should not be used
during breast-feeding.

https://assets.publishing.service.gov.uk/gove...ionals.pdf

This could be good for GNBT if we can get the ball rolling













(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site